Introduction {#Sec1}
============

Early diagnosis of acute cholecystitis allows prompt treatment and reduces both mortality and morbidity. The accurate diagnosis of typical as well as atypical cases of acute cholecystitis requires specific diagnostic criteria. Acute cholecystitis has a better prognosis than acute cholangitis, but may require immediate management, especially in patients with torsion of the gallbladder and emphysematous, gangrenous, or suppurative cholecystitis. The lack of standard criteria for diagnosis and severity assessment is reflected by the wide range of reported mortality rates in the literature, and this lack makes it impossible to provide standardized optimal treatment guidelines for patients. In these Guidelines we propose specific criteria for the diagnosis and severity assessment of acute cholecystitis, based on the best available evidence and the experts' consensus achieved at the International Consensus Meeting for the Management of Acute Cholecystitis and Cholangitis, held on April 1--2, 2006, in Tokyo.

Diagnostic criteria for acute cholecystitis {#Sec2}
===========================================

Diagnosis is the starting point of the management of acute cholecystitis, and prompt and timely diagnosis should lead to early treatment and lower mortality and morbidity. Specific diagnostic criteria are necessary to accurately diagnose typical, as well as atypical cases. The Guidelines propose diagnostic criteria for acute cholecystitis (Table [1](#Tab1){ref-type="table"}). C-reactive protein (CRP) is not commonly measured in many countries. However, because acute cholecystitis is usually associatied with an elevation of CRP level by 3 mg/dl or more, CRP was included. Diagnosis of acute cholecystitis by elevation of CRP level (3 mg/dl or more), with ultrasonographic findings suggesting acute cholecystitis, has a sensitivity of 97%, specificity of 76%, and positive predictive value of 95% (level 1b).[@CR1] After the discussion during the Tokyo International Consensus Meeting, almost unanimous agreement was achieved on the criteria (Table [2](#Tab2){ref-type="table"}). However, 19% of the panelists from abroad expressed the necessity for minor modifications, because, in the provisional version, the diagnostic criteria did not include technetium hepatobiliery iminodiacetic acid (Tc-HIDA) scan as an item. Table 1Diagnostic criteria for acute cholecystitisA. Local signs of inflammation etc.:(1) Murphy's sign, (2) RUQ mass/pain/tendernessB. Systemic signs of inflammation etc.:(1) Fever, (2) elevated CRP, (3) elevated WBC countC. Imaging findings: imaging findings characteristic of acute cholecystitisDefinite diagnosis(1) One item in A and one item in B are positive(2) C confirms the diagnosis when acute cholecystitis is suspected clinicallyNote: acute hepatitis, other acute abdominal diseases, and chronic cholecystitis should be excludedTable 2Answer pad responses on the diagnostic criteria for acute cholecystitisAgreeAgree, but needs minor modificationsDisagreeTotal (*n* = 110)92%8%0%Panelists from abroad (*n* = 21)81%19%0Japanese panelists (*n* = 20)100%0%0%Audience (*n* = 69)93%7%0%

Imaging findings of acute cholecystitis {#Sec3}
---------------------------------------

Ultrasonography findings (level 4)[@CR2]--[@CR5]Sonographic Murphy sign (tenderness elicited by pressing the gallbladder with the ultrasound probe)Thickened gallbladder wall (\>4 mm; if the patient does not have chronic liver disease and/or ascites or right heart failure)Enlarged gallbladder (long axis diameter \>8 cm, short axis diameter \>4 cm)Incarcerated gallstone, debris echo, pericholecystic fluid collectionSonolucent layer in the gallbladder wall, striated intramural lucencies, and Doppler signals.Magnetic resonance imaging (MRI) findings (level 1b--4)}[@CR6]--[@CR9]Pericholecystic high signalEnlarged gallbladderThickened gallbladder wall.Computed tomography (CT) findings (level 3b)[@CR10]Thickened gallbladder wallPericholecystic fluid collectionEnlarged gallbladder Linear high-density areas in the pericholecystic fat tissue.Tc-HIDA scans (level 4)[@CR11],[@CR12]Non-visualized gallbladder with normal uptake and excretion of radioactivityRim sign (augmentation of radioactivity around the gallbladder fossa).

Severity assessment criteria of acute cholecystitis {#Sec4}
===================================================

Concept of severity grading of acute cholecystitis {#Sec5}
--------------------------------------------------

Patients with acute cholecystitis may present with a spectrum of disease stages ranging from a mild, self-limited illness to a fulminant, potentially life-threatening illness. In these Guidelines we classify the severity of acute cholecystitis into the following three categories: "mild (grade I)", "moderate (grade II)", and "severe (grade III)". A category for the most severe grade of acute cholecystitis is needed because this grade requires intensive care and urgent treatment (operation and/or drainage) to save the patient's life. However, the vast majority of patients present with less severe forms of the disease. In these patients, the major practical question regarding management is whether it is advisable to perform cholecystectomy at the time of presentation in the acute phase or whether other strategies of management should be chosen during the acute phase, followed by an interval cholecystectomy. Therefore, to guide the clinician, the severity grading includes a "moderate" group based on criteria predicting when conditions might be unfavorable for cholecystectomy in the acute phase (level 2b--4).[@CR13]--[@CR18] Patients who fall neither into the severe nor the moderate group form the majority of patients with this disease; their disease is suitable for management by cholecystectomy in the acute phase, if comorbidities are not a factor. Definitions of the three grades are given below.

Mild (grade I) acute cholecystitis {#Sec6}
----------------------------------

Mild acute cholecystitis occurs in a patient in whom there are no findings of organ dysfunction, and there is mild disease in the gallbladder, allowing for cholecystectomy to be performed as a safe and low-risk procedure. These patients do not have a severity index that meets the criteria for "moderate (grade II)" or "severe (grade III)" acute cholecystitis.

Moderate (grade II) acute cholecystitis {#Sec7}
---------------------------------------

In moderate acute cholecystitis, the degree of acute inflammation is likely to be associated with increased operative difficulty to perform a cholecystectomy (level 2b--4).[@CR13]--[@CR18]

Severe (grade III) acute cholecystitis {#Sec8}
--------------------------------------

Severe acute cholecystitis is associated with organ dysfunction.

Criteria for the severity assessment of acute cholecystitis {#Sec9}
-----------------------------------------------------------

Acute cholecystitis has a better outcome/prognosis than acute cholangitis but requires prompt treatment if gangrenous cholecystitis, emphysematous cholecystitis, or torsion of the gallbladder are present. The progression of acute cholecystitis from the mild/moderate to the severe form means the development of the multiple organ dysfunction syndrome (MODS). Organ dysfunction scores, such as Marshall's multiple organ dysfunction (MOD) score, and the sequential organ failure assessment (SOFA) score, are sometimes used to evaluate organ dysfunction in critically ill patients. The Guidelines classify the severity of acute cholecystitis into three grades (Tables [3](#Tab3){ref-type="table"}--[5](#Tab5){ref-type="table"}): "severe (grade III)": acute cholecystitis associated with organ dysfunction, "moderate (grade II)": acute cholecystitis associated with difficulty to perform cholecystectomy due to local inflammation, and "mild (grade I)": acute cholecystitis which does not meet the criteria of "severe" or "moderate" acute cholecystitis (these patients have acute cholecystitis but no organ dysfunction, and there are mild inflammatory changes in the gallbladder, so that a cholecystectomy can be performed with a low operative risk). Almost unanimous agreement on the criteria was achieved (Tables [6](#Tab6){ref-type="table"} and [7](#Tab7){ref-type="table"}). When acute cholecystitis is accompanied by acute cholangitis, the criteria for the severity assessment of acute cholangitis should also be taken into account. Being "elderly" per se is not a criterion for severity itself, but indicates a propensity to progress to the severe form, and thus is not included in the criteria for severity assessment. Table 3Criteria for mild (grade I) acute cholecystitis"Mild (grade I)" acute cholecystitis does not meet the criteria of "severe (grade III)" or "moderate (grade II)" acute cholecystitis. Grade I can also be defined as acute cholecystitis in a healthy patient with no organ dysfunction and only mild inflammatory changes in the gallbladder, making cholecystectomy a safe and low-risk operative procedure.Table 4Criteria for moderate (grade II) acute cholecystitis"Moderate" acute cholecystitis is accompanied by any one of the following conditions:1. Elevated WBC count (\>18 000/mm^3^)2. Palpable tender mass in the right upper abdominal quadrant3. Duration of complaints \>72 h^a^4. Marked local inflammation (biliary peritonitis, pericholecystic abscess, hepatic abscess, gangrenous cholecystitis, emphysematous cholecystitis)^a^ Laparoscopic surgery in acute cholecystitis should be performed within 96 h after the onset (level 2b-4)[@CR13],[@CR14],[@CR16]Table 5Criteria for severe (grade III) acute cholecystitis"Severe" acute cholecystitis is accompanied by dysfunctions in any one of the following organs/systems1. Cardiovascular dysfunction (hypotension requiring treatment with dopamine ≧5 µg/kg per min, or any dose of dobutamine)2. Neurological dysfunction (decreased level of consciousness)3. Respiratory dysfunction (PaO~2~/FiO~2~ ratio \<300)4. Renal dysfunction (oliguria, creatinine \>2.0 mg/dl)5. Hepatic dysfunction (PT-INR \>1.5)6. Hematological dysfunction (platelet count \<100 000/mm^3^)Table 6Answer pad responses on the criteria for severe (grade III) acute cholecystitisAgreeAgree, but needs minor modificationsDisagreeTotal (*n* = 110)90%10%0%Panelists from abroad (*n* = 21)95%5%0Japanese panelists (*n* = 21)81%19%0%Audience (*n* = 68)91%9%0%Table 7Answer pad responses on the criteria for moderate (grade II) acute cholecystitisAgreeAgree, but needs minor modificationsDisagreeTotal (*n* = 109)78%22%0%Panelists from abroad (*n* = 22)77%23%0%Japanese panelists (*n* = 22)91%9%0%Audience (*n* = 65)74%26%0%

Discussion at the Tokyo International Consensus Meeting {#Sec10}
=======================================================

Diagnostic criteria for acute cholecystitis {#Sec11}
-------------------------------------------

The clinical diagnosis of acute cholecystitis is traditionally based on the patient's clinical presentation, and it is confirmed by the imaging findings. Hence, the initial provisional diagnostic criteria for acute cholecystitis comprised: (1) clinical signs and symptoms, (2) laboratory data, and (3) imaging findings. In the discussion on criteria for "clinical signs and symptoms", 92% of the Japanese panelists agreed, whereas only 65% of the panelists from abroad agreed and 4% disagreed. In regard to the criteria for "laboratory data", 20% of the Japanese panelists and 39% of the panelists from abroad voted "agree, but needs minor modifications". After a discussion among the panelists, several changes were made. In regard to the proposed criteria for "imaging findings", 66%--71% of the Japanese panelists agreed and about 30% of the panelists voted "agree, but needs minor modifications", and 4% of the panelists from abroad disagreed, because Tc-HIDA scans were not included. Discussion at the International Consensus Meeting led to the reorganization of these categories as: (1) local signs of inflammation, (2) systemic signs of inflammation, and (3) imaging findings. "Suspected diagnosis" in the provisional criteria was deleted, and two conditions for "definite diagnosis" were established in the final diagnostic criteria. After the discussion, 100% of the Japanese panelists and 81% of the panelists from abroad agreed on the final version (refer to Tables 1 and 2; consensus was reached).

Severity assessment criteria for acute cholecystitis {#Sec12}
----------------------------------------------------

Concerning criteria for severe (grade III) acute cholecystitis, 81% of the Japanese panelists and 95% of the panelists from abroad agreed with the criteria (refer to Tables [5](#Tab5){ref-type="table"} and [6](#Tab6){ref-type="table"}; consensus was reached). The acute physiology and chronic health evaluation II (APACHE II) score was not included in the assessment criteria, because it is too complicated to apply in community hospitals.

The criteria for moderate (grade II) acute cholecystitis can be defined as acute cholecystitis associated with local inflammatory conditions that make cholecystectomy difficult (Steven Strasberg, USA; Dirk J. Gouma, the Netherlands; Henry Pitt, USA; Sheung-Tat Fan and Joseph W.Y. Lau, Hong Kong; Serafin C. Hilvano, Philippines). On the basis of these aspects, the final criteria for moderate (grade II) acute cholecystitis were defined and were agreed on by 91% of the Japanese panelists and 77% of those from abroad (refer to Tables [4](#Tab4){ref-type="table"} and [7](#Tab7){ref-type="table"}; consensus was reached).

The criteria for mild (grade I) acute cholecystitis were agreed on by approximately 90% of both the Japanese panelists and the panelists from abroad (consensus was reached).
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